sanofi • 75
KARDEGIC
Product Insights
KARDEGIC is a 75 mg DL-lysine acetylsalicylate powder designed for oral solution, providing rapid antiplatelet action for cardiovascular patients. Its composition includes lactose as an excipient, making it unsuitable for individuals with lactose intolerance, and it falls into the ultra-processed NOVA 4 category. The product requires medical supervision and should be dissolved in water and taken as prescribed.
Comparative Analysis
In the antiplatelet drug market, KARDEGIC stands out by offering a fast-dissolving 75 mg DL-lysine aspirin powder that provides precise dosing and quick absorption, differentiating it from conventional tablet aspirin.
Ingredients
KARDEGIC®75mg acétylsalicylate de DL-Lysine Poudre pour solution buvable Sachet-dose Voie orale Excipient effet notoire: Lactose. UCD 3400892065366 SANOFI
Unlock Full Product Insights
Scan this and millions of other daily products to reveal hidden ingredients, safety alerts, and comprehensive analysis with the free NutrScan app.
Frequently Asked Questions
Everything you need to know about KARDEGIC.
